Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma

Franck Morschhauser; Martin J.S. Dyer; Harriet S. Walter; Alexey V. Danilov; Loic Ysebaert; Daniel James Hodson; Christopher Fegan; Simon A. Rule; John Radford; Guillaume Cartron; Krimo Bouabdallah; Andrew John Davies; Stephen Spurgeon; Nishanthan Rajakumaraswamy; Biao Li; Rita Humeniuk; Xi Huang; Pankaj Bhargava; Juliane M. Jürgensmeier; Gilles Salles

Journal ArticleOPEN ACCESS

Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma

Leukemia (2021) 35(7) 2108-2113

DOI: 10.1038/s41375-020-01108-x

15Citations

15Readers

Cite

CITATION STYLE

APA

Morschhauser, F., Dyer, M. J. S., Walter, H. S., Danilov, A. V., Ysebaert, L., Hodson, D. J., … Salles, G. (2021). Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma. Leukemia, 35(7), 2108–2113. https://doi.org/10.1038/s41375-020-01108-x

Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma

Cite

Register to see more suggestions